Open menu

Medtronic Insulin Pumps

Medtronic pumps available in Canada include the MiniMed 630G and the MiniMed 670G & 770G Hybrid Closed-Loop insulin pumps. 

Medtronic Minimed 670G named

Medtronic MiniMed 770G Named 2020

770G Overview 

The Medtronic 770G insulin pump was approved by Health Canada in December, 2020 and will soon be available in Canada (first quarter 2021).

  • The 770G will be upgradeable via software.
  • The pump and transmitter are both new.
  • The glucose sensor (Guardian Sensor 3) is the same as used with 670G. It requires twice daily calibrations.
  • The pump and new transmitter will communicate to each other and to a MiniMed Mobile phone app via Bluetooth.
  • Data will be visible on the app and will be uploaded to Carelink (cloud server) automatically. The app will not program the pump.
  • As per Medtronic's previous pump model, the option exists to use suspend-before-low or in addition to that, to allow for more automated insulin adjustments (e.g. AutoMode). 
  • Carb counting and manual meal bolusing are required. 
  • For more information visit Medtronic

670G Overview 

The Auto Mode feature of the Medtronic 670G pump automatically adjusts basal insulin every 5 minutes.  "Setting" basal insulin profiles by missing meals is not required because:

  • Auto Mode feature functions like a “dimmer switch”. It turns basal insulin up, down or off to attempt to maintain a target of 6.7 mmol/L (before and after meals). A temporary target of 8.3 mmol/L may be programmed by the pump user.
  • Medtronic's proprietary (and unseen) algorithm uses recent and past glucose readings to determine basal insulin needs.
  • The basal insulin provided is different every day. There will be times the patient receives no (zero) basal insulin. See here. 

The Auto Mode feature makes suggestions for correction insulin and meal bolus insulin. Patients must still accurately count carbohydrate and program into the pump. The pump's bolus advice for meals and corrections can be accepted or declined by the paitent. However, it cannot be modified. 

In Auto Mode, patients will only be able to control the:

  • Active insulin time
  • Carbohydrate ratio. 

The following are NOT available for use when the 670G is in Auto Mode (they are available in Manual Mode):

  • Temporary basal
  • Insulin sensitivity factor - ISF (The algorithm determines a correction dose based on recent insulin delivery, not on ISF. The patient may accept or decline the dose.)
  • Dual or square wave bolus
  • Pre-set boluses
  • Easy bolus
  • Manual bolus
  • Remote bolus

Additional Auto Mode information:

  • Auto Mode requires regular blood glucose calibrations of CGM and additional blood glucose tests when the pump requests.
  • The pump can exit out of Auto Mode under certain conditions. In this case, the pump will use "Safe Basal."
  • Safe Basal is an automatic function. It is a constant basal rate based on recent insulin delivery history. No automatic adjustment of basal rates is done in Safe Basal and the sensor glucose data is not used. Safe Basal allows the user time to take the actions needed to resume Auto Mode (eg. input a blood glucose reading). If actions aren't taken to resume Auto Mode, then after 90 minutes of Safe Basal the pump will return to Manual Mode (e.g. it will function like a normal pump using programmed pump basal settings).
  • Although Auto Mode delivers a different amount of basal insulin each day, periodically the manual basal rates should be updated to reflect the overall pattern of recent Auto Mode basal insulin delivery as seen in Carelink reports.

Training 

Carelink Setup Training for 670G

Medtronic Resources: Videos & PDF Handouts 


  • Cannula Fills
    Set Name Cannula Length Cannula Fill
    Silhouette 13 mm or 17 mm 0.7 unit
    Mio 30  13 mm 0.7 unit
    Quick Set 6 mm
    9 mm
    0.3 unit
    0.5 unit
    Mio 6 mm
    9 mm
    0.3 unit
    0.5 unit
    Mio Advanced 6 mm 0.6 unit
    Sure-T 6 mm or 8 mm Zero unit

Company Contacts

  • CONTACTS- MEDTRONIC
    • Medtronic Canada
    • Customer care: 1-800-284-4416 
    • Diabetes Territory Manager (Southern Alberta): This email address is being protected from spambots. You need JavaScript enabled to view it. 1-403-829-1932
    • Diabetes Clinical Specialist (Alberta): This email address is being protected from spambots. You need JavaScript enabled to view it.  1-403-831-4102
  • FIELD SAFETY NOTIFICATIONS (Canada)
    • 2021-03-09 Advise patients not to use CGM while taking hydroxyurea: Medications with hydroxyurea could result in falsely elevated sensor glucose (SG) readings in enhanced Enlite™ sensor or a Guardian™ Sensor (3). Hydroxyurea is also known in Canada by other names, such as Hydrea™, Apo-Hydroxyurea™, Mylan-Hydroxyurea™*or hydroxycarbamide. (note, also impacted are readings from Dexcom G5 & 6 but not Libre see here
    • 2020-03 Medtronic 630G Incorrect Rise Alert
    • 2019-11 Medtronic Series 600 Pump Retainer Ring